Qube Research & Technologies (QRT)
INTS icon

Qube Research & Technologies (QRT)’s Intensity Therapeutics INTS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$10 – 3701
2024
Q2 		– Sell
-444
Closed -$50.4K – 3610
2024
Q1 		$57.7K Buy
444
+197
+80% +$23.6K ﹤0.01% 3469
2023
Q4 		$52.8K Buy
+247
New +$26K ﹤0.01% 3301

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s INTS Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Intensity Therapeutics (INTS) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3701.

Qube Research & Technologies (QRT) first reported a position in INTS in Q4 2023 and has held it in 2 quarters since. The position peaked at $57.7K in Q1 2024. 20 funds tracked by Wall St. Rank hold INTS as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Intensity Therapeutics worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Intensity Therapeutics share count unchanged in Q3 2024.
  • Intensity Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3701 holding.
  • Qube Research & Technologies (QRT) first reported a position in Intensity Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • Qube Research & Technologies (QRT)'s Intensity Therapeutics position peaked at $57.7K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.